Product Images Simvastatin

This is a prescription medication named Simvastatin that comes in the form of tablets with strength of 10 mg. The quantity of tablets per package is 90. The NDC number is 70518-0064-00 and it is manufactured by Accord in Durham, NC. The medication should be stored at a temperature of 20-25°C. The package should be kept out of reach of children. Directions for use should be read from the package insert. The medication is packaged by RemedyRepack Inc. in Indiana, PA.*

RXCONLY is a medication used for the treatment of hyperlipidemia. The drug contains 10 mg Simvastatin per tablet and is packaged by RemedyRepack, NC. The medicine comes in a bottle of 30 tablets, and the consumption instructions are given in the package insert. It has an NDC number of 70518-0064-01 and is manufactured by Accord, Durham, NC 27703. It should be kept out of the reach of children and stored at room temperature. The expiry date and OT# are not available.*

This is a prescription medication for Simvastatin 10 mg tablets. The package contains 30 tablets, and the manufacturer is Accord located in Durham, NC 27703. The medication should be kept away from children, and the directions for use can be found in the package insert. The medication should be stored at a temperature between 20-25°C (83-77°F) with excursions permitted to 15-30°C (53-86°F) [See USP]. The package was repackaged by RemedyRepack Inc., located in Indiana, PA 15701, contactable at 724.465.8762.*

This is a description of a medication called Simvastatin, with a strength of 10mg and sold in tablet form. It contains an NDC number of 70518-0064-02 and the manufacturer is Accord located in Durham, NC. It is important to store at temperatures ranging from 20-25°C and keep out of reach of children. Directions for use can be found in the package insert. This medication was packaged by RemedyRepack Inc. in Indiana, PA.*

This is a table showing the baseline characteristics of 11 patients with and without chronic pain. The table includes information on diabetes mellitus, peripheral vascular disease, cerebrovascular disease, gender, age, LDL-cholesterol, HDL-cholesterol, major vascular events, and major coronary events. There are also risk ratios and confidence intervals represented graphically. Simvastatin tablets seem to be involved in the study.*